Browsing by Author "Forte, Anabel"

Now showing items 1-4 of 4

    • A shared-parameter joint model for prostate cancer risk and psa longitudinal profiles 

      Serrat Piè, Carles; Rué, Montserrat; Perpiñán Fabuel, Hèctor; Forte, Anabel; Armero, Carmen; Piulachs Lozada Benavente, Xavier; Páez, Álvaro; Gómez Melis, Guadalupe (Fundación Mapfre, 2015)
      Conference report
      Open Access
      The paper describes the use of frequentist and Bayesian shared-parameter joint models of longitudinal measurements of prostate specific antigen (PSA) and the risk of prostate cancer (PCa). The motivating dataset corresponds ...

    • Exploring Bayesian models to evaluate control procedures for plant disease 

      Alvares, Danilo; Armero, Carmen; Forte, Anabel; Rubio, Luis (Institut d'Estadística de Catalunya, 2016-06-17)
      Article
      Open Access
      Tigernut tubers are the main ingredient in the production of orxata in Valencia, a white soft sweet popular drink. In recent years, the appearance of black spots in the skin of tigernuts has led to important economic losses ...

    • Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data 

      Serrat Piè, Carles; Rué, Montserrat; Armero, Carmen; Piulachs Lozada Benavente, Xavier; Perpiñán Fabuel, Hèctor; Forte, Anabel; Páez, Álvaro; Gómez Melis, Guadalupe (Taylor & Francis, 2015-06-03)
      Article
      Open Access
      The paper describes the use of frequentist and Bayesian shared-parameter joint models of longitudinal measurements of prostate-specific antigen (PSA) and the risk of prostate cancer (PCa). The motivating dataset corresponds ...

    • Joint modelling analysis of prostate cancer incidence: frequentist and bayesian approaches 

      Piulachs Lozada Benavente, Xavier; Serrat Piè, Carles; Rué, Montserrat; Armero, Carmen; Forte, Anabel; Perpiñán, Héctor; Luján, Marcos; Páez, Álvaro (2013)
      Conference lecture
      Open Access
      Prostate specific antigen (PSA) is a biomarker for prostate cancer (PCa) that is widely used for PCa screening. Using a database of 2415 men included in the Spanish screening arm of the ERSPC Study, we will use joint ...